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ABSTRACT
To identify genes controlling volatile anesthetic (VA) action, we have screened through existing Caeno-
rhabditis elegans mutants and found that strains with a reduction in Go signaling are VA resistant. Loss-of-
function mutants of the gene goa-1, which codes for the a-subunit of Go, have EC50s for the VA isoflurane
of 1.7- to 2.4-fold that of wild type. Strains overexpressing egl-10, which codes for an RGS protein negatively
regulating goa-1, are also isoflurane resistant. However, sensitivity to halothane, a structurally distinct VA,
is differentially affected by Go pathway mutants. The RGS overexpressing strains, a goa-1 missense mutant
found to carry a novel mutation near the GTP-binding domain, and eat-16(rf ) mutants, which suppress
goa-1(gf ) mutations, are all halothane resistant; goa-1(null) mutants have wild-type sensitivities. Double
mutant strains carrying mutations in both goa-1 and unc-64, which codes for a neuronal syntaxin previously
found to regulate VA sensitivity, show that the syntaxin mutant phenotypes depend in part on goa-1
expression. Pharmacological assays using the cholinesterase inhibitor aldicarb suggest that VAs and GOA-1
similarly downregulate cholinergic neurotransmitter release in C. elegans. Thus, the mechanism of action
of VAs in C. elegans is regulated by Goa, and presynaptic Goa-effectors are candidate VA molecular targets.
THE synapse is the probable arena where general Ganetzky and Wu 1982; Wu et al. 1983), the not yetanesthetics depress neuronal function (Pocock molecularly identified halothane-resistant har genes
and Richards 1991, 1993; Franks and Lieb 1994). In (Nishikawa and Kidokoro 1999), and Caenorhabditis
part due to technical limitations, most studies of anes- elegans genes coding for SNARE proteins (van Swind-
thetic action have focused on postsynaptic putative tar- eren et al. 1999), are thought to regulate synaptic trans-
gets such as GABAA receptors (Franks and Lieb 1994; mitter release. In C. elegans reduction-of-function muta-
Mihic et al. 1997); however, presynaptic transmitter re- tions in genes coding for synaptic vesicle machinery
lease is also inhibited by clinical concentrations of vola- proteins drastically alter VA sensitivity. In general, these
tile anesthetics (VAs) and various molecular mediators mutants, which all have reduced cholinergic synaptic
for this effect have been proposed (Zorychta and transmission, were VA hypersensitive; however, a splice-
Capek 1978; Takenoshita and Takahashi 1987; Kull- site mutant in syntaxin that similarly reduced neuro-
mann et al. 1989; Miao et al. 1995; Perouansky et al. transmitter release was highly VA resistant. Thus, an
1995; Schlame and Hemmings 1995; MacIver et al. indirect effect of reduction of syntaxin function could
1996; Nishikawa and MacIver 2000). Thus, in vitro not explain the VA resistance; rather, the data suggest
studies have revealed several potentially relevant molec- that the mutant protein directly alters VA binding or
ular mechanisms for general anesthesia. Which, if any, efficacy and implicates syntaxin or syntaxin-binding pro-
are operant in vivo is unknown. Genetic investigations teins as potential anesthetic targets (van Swinderen et
are a means toward identifying gene products control- al. 1999).
ling anesthetic action in vivo. To better understand the presynaptic VA mechanism
Few genes have been identified that regulate sensitiv- in C. elegans, we have begun to examine the effect on
ity to clinical concentrations of anesthetics (Krishnan VA sensitivity of genes known to regulate transmitter
and Nash 1990; Tinklenberg et al. 1991; Leibovitch release. Go has been shown to regulate negatively synap-
et al. 1995; Gamo et al. 1998; Quinlan et al. 1998; van tic transmission in vertebrates in part by its bg-subunit
Swinderen et al. 1999). Most of these “anesthesia” directly binding to and inhibiting non-L type Ca21 chan-
genes, which include Drosophila shaker (Jan et al. 1977; nels (Dolphin et al. 1993; Hescheler and Schultz
1994; Sudhof 1995; Zhang et al. 1996). Go regulation
of some presynaptic Ca21 channel subtypes appears to
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rescues the Dpy phenotype of dpy-20(e1282). pJMGO containset al. 1995; Koelle and Horvitz 1996; Hajdu-Cronin
a full-length wild-type copy of goa-1 genomic DNA includinget al. 1999; Nurrish et al. 1999). The behavioral and
its native promoter inserted into pBluescript1. pJMGOHS con-
pharmacological phenotypes of null alleles of C. elegans tains a full-length wild-type copy of goa-1 genomic DNA mi-
goa-1, which codes for the neuronally expressed Goa- nus its native promoter inserted into pPD49.78, which has
the heat-shock-inducible promoter from the hsp 16-2 genesubunit, are indeed consistent with a disinhibition of
(Stringham et al. 1992; Mello and Fire 1995). Non-Dpy F1transmitter release (Mendel et al. 1995; Segalat et al.
transformants were chosen, and stably transformed lines were1995; Miller et al. 1999; Nurrish et al. 1999). In C.
examined for phenotypic rescue. For rescue of goa-1(n363),
elegans, the presynaptic mechanisms of Go are mediated n363/1 males were crossed with dpy-20(e1282);syEx352 her-
in part by inhibition of a Gqa, phospholipase C b, diacyl- maphrodites, and Egl hermaphrodite F1 progeny (presumed
syEx352-containing animals) were picked onto individualglycerol pathway that stimulates transmitter release at
plates. Non-Dpy Egl F2 progeny were picked from plates thatcholinergic motor neuron terminals. Here, we test the
also segregated loopy/hyperactive Dpy progeny. Strains thathypothesis that Go regulates VA action and find that
segregated both loopy/hyperactive and Egl nonhyperactive
an intact Go signaling pathway is required for normal in an z1:1 ratio for multiple generations were kept for testing
sensitivity to VAs, that goa-1(rf ) mutants antagonize the and presumed to have the genotype goa-1(n363);syEx352. We
were unable to isolate loopy/hyperactive Dpy progeny fromanesthetic phenotype of syntaxin mutants, and that Go
Egl animals despite multiple attempts, suggesting that n363,regulates the sensitivity of two structurally distinct VAs
e1282, and syEx352 are synthetic lethal or at least have unfavor-differently.
able growth characteristics. This question, however, was not
directly tested. For induction of goa-1(1) expression in PS3480,
agar plates containing young adult animals grown at 208 wereMATERIALS AND METHODS
placed in a 348 oven for 4 hr and then the animals were
allowed to recover for 2 hr at 208 prior to behavioral testing.Strains and culture conditions: C. elegans mutant strains were
Behavioral assays and statistics: Anesthetic assays: The dis-obtained from the Caenorhabditis Genetics Center, which is
persal assay as described previously was used to measure thefunded by the National Institutes of Health National Center
locomotion defects produced by VAs (Crowder et al. 1996;for Research Resources, and from several laboratories whose
van Swinderen et al. 1997). Between 300 and 500 nematodesresearch is referenced in this work. Strains were grown as
were washed off NGM plates with 1 ml of S-basal (Sulstondescribed (Brenner 1974) on nematode growth media (NGM)
and Brenner 1974) into plastic Eppendorf tubes. The animalsagar in uncrowded conditions (200–300 animals per plate).
were subsequently washed twice more with S-basal and onceThe following strains and alleles were used in this work. Wild-
with distilled water by allowing most to settle and immediatelytype worms were N2 (var. Bristol). Mutant strains used for this
removing the supernatant. Following the last wash in water,work are as follows:
the animals were resuspended in 100 ml of distilled water and
LGI: goa-1(n363), goa-1(sy192), goa-1(n1134), goa-1(pk62), immediately aliquoted in 10-ml samples containing 50–100
eat-16(sy438), eat-16(ad702) worms onto the center of a dispersal assay plate, which is a
PS3479: goa-1(sy192);dpy-20(e1282);syEx352[pJMGO;pMH86] 9.5-cm NGM plate seeded at its edge 1–2 days prior to the
PS3480: goa-1(sy192);dpy-20(e1282);syEx353[pJMGOHS; assay with a thin ring of OP50 Escherichia coli (Brenner 1974).
pMH86] The preparations were then placed into sealed glass chambers
MC21: goa-1(n363);syEx352 and exposed to various concentrations of anesthetic. VAs were
LGIII: unc-64(md130), unc-64(js21), unc-64(md1259) delivered as described previously (Crowder et al. 1996; van
LGIV: dpy-20(e1282) Swinderen et al. 1997). We have previously shown that with
LGV: egl-10(md176), egl-10(n480) this delivery method VAs rapidly disrupt C. elegans behaviors
LGX: sag-1(sy428), sag-1(sy429), sag-1(nu199), sag-1(md1777), including locomotion with steady state effects reached within
lin-15(n765)nIs51[egl-10(1)lin-15(1)], lin-15(n765)nIs54 10 min (Crowder et al. 1996). As soon as the 10-ml water
[egl-10(1)lin-15(1)]. aliquot dried (typically in 5 min), the preparation was briefly
shaken to induce the animals to unclump and begin dispers-Note that sag-1 is also known as dgk-1. By standard methods
ing. The assay was then allowed to run its course untouched(Huang and Sternberg 1995), goa-1;unc-64 double mutant
for 45 min. Then, the fraction of animals having reached thestrains (loopy Unc phenotypes) were isolated from the brood
bacterial ring divided by the total was scored as the dispersalof Unc animals segregating from goa-1/1;unc-64(rf)/1 hetero-
index. Concentration/response data were fitted by nonlinearzygotes. The presumed double mutant genotypes were con-
regression to estimate EC50s (the e ffective VA concentrationfirmed by crossing with N2 males and finding the presence
for a 50% reduction in the dispersal index), slopes, and stan-of both single mutant phenotypes in the F2 progenies. To assay
dard errors of the estimate using the equation: y 5 min 1heterozygous goa-1 mutants, N2 males were mated to goa-1;
(max 2 min)/(1 1 (x/x50)2k) where y 5 the dispersal index;dpy-20(e1282) hermaphrodites, and their non-Dpy progeny
min 5 the minimum dispersal index, which was assumed towere scored. All assays were performed on well-fed young adult
be zero for all curves because all approached zero; max 5animals at room temperature (218–238). For egg-laying, body
the average of the maximum dispersal indices for that strain;bend, and aldicarb assays, staged adults, z24 hr after being
x 5 [VA]; x50 5 the EC50; and k 5 the slope of the curve. Theselected as L4 larvae, were used.
EC50 was used as the measure of the VA sensitivity of the strain.Transformation rescue: For rescue of the hyperactive and
Significant resistance or hypersensitivity of a strain’s EC50 wasanesthetic-resistant phenotypes of goa-1(sy192) and goa-1
determined relative to the wild-type strain N2 by simultaneous(n363), goa-1(sy192);dpy-20(e1282) was transformed by gonadal
curve fitting (Waud 1972; DeLean et al. 1978; van Swindereninjection (Mello and Fire 1995) with pMH86 (15 ng/ml)
et al. 1997).and either pJMGO (5 ng/ml) or pJMGOHS (5 ng/ml) along
For transformation rescue experiments, dispersal assayswith pBluescript1 (180 ng/ml) as carrier DNA. pMH86 con-
were performed as described above with animals washed fromtains a full-length wild-type copy of dpy-20 genomic DNA in-
cluding its native promoter inserted into pBluescript. pMH86 plates segregating both Dpy or non-Egl (nontransformed)
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and non-Dpy or Egl (transformed) progeny. Dispersal indices
were calculated independently for transformed and nontrans-
formed animals with both genotypes present on the same dis-
persal plates.
Aldicarb assay: Aldicarb is an inhibitor of cholinesterases that
paralyzes C. elegans due to excess acetylcholine accumulating at
the synapse producing a hypercontracted state (Nguyen et al.
1995; Miller et al. 1996). Loss-of-function mutations in genes
coding for neurotransmitter release machinery confer resis-
tance to aldicarb, presumably by reducing transmitter release
and counteracting the effect of aldicarb (Rand and Nonet
1997). The effect of VAs on the aldicarb sensitivity of wild-
type and mutant strains was tested as described previously
(van Swinderen et al. 1999). Briefly, 20–30 young adult ani-
mals were placed onto seeded NGM plates containing a spe-
cific dose of aldicarb mixed in the agar. After 4 hr of exposure,
the animals were picked into a circle of 0.5-cm diameter on
the same aldicarb plate. This preparation was then exposed,
in triplicate, to various concentrations of VA as described Figure 1.—Isoflurane concentration-response curves for
above, including a no-anesthetic control. The fraction of ani- the wild-type N2 and goa-1(n363) strains. The dispersal index,
mals that crawled completely out of the circle after 1 hr was the fraction of animals moving in 45 min from the center to
tallied as the movement index. Different mutant strains re- the edge of a 9.5-cm agar pad rimmed with bacteria, is plotted
quired different aldicarb concentrations in order to paralyze against isoflurane concentration to estimate the sensitivity of
the majority of animals. To allow comparison of the different the strains to anesthetic. The EC50 for N2 in isoflurane is
strains, we used an aldicarb concentration where the move- 0.75 6 0.02 vol%. For goa-1(n363), the EC50 is 1.40 6 0.06
ment index was 5–20% of that in the absence of VAs. The vol%. goa-1(n363) is significantly resistant by simultaneous
significance of differences between movement indices was de- curve-fitting methods (Waud 1972; DeLean et al. 1978; van
termined by a two-tailed Student’s t-test. Swinderen et al. 1997) compared to N2 (P , 0.01). Data
Egg-laying assays: Young adult hermaphrodites were placed points for similar isoflurane concentrations are pooled, and
individually on standard culture plates and eggs were har- the mean 6 SEM of the concentrations and dispersal indices
vested at 15-min intervals. The number of cells in each freshly are represented by horizontal and vertical error bars, respec-
laid egg were counted using Nomarski optics. Eggs having tively.
eight or fewer cells were classified as early. For all genotypes,
eggs were harvested from at least 10 hermaphrodites.
Locomotion assays: To calculate forward locomotion rate and fragment were sequenced by the Caltech DNA sequencing
the frequency of spontaneous backing in the absence of VAs, facility on an automated sequencing machine (Applied Biosys-
staged adult hermaphrodites were observed under conditions tems, Foster City, CA). Mismatches were resequenced on the
that maximize forward locomotion and minimize other behav- opposite strand.
iors: 200 ml of a fresh 5-ml OP50 E. coli culture was spread
over the entire surface of a 60-mm NGM plate preincubated
at 208. Immediately after drying plates were covered and used RESULTS
within 2 hr. Animals were transferred to these thin lawn plates
without adding extra food and were left undisturbed for 3 min goa-1 mutants are resistant to isoflurane: The VA
prior to observation. Seconds elapsed per sine wave (counting isoflurane disrupts normal locomotion in C. elegans
anterior flexing just posterior to the pharynx) and the number (Crowder et al. 1996; van Swinderen et al. 1997). The
of times that backing was initiated were recorded over a 2-min
EC50 or isoflurane concentration that half maximallyperiod using a keystroke recorder written by Hou-Pu Chou
disrupts coordinated movement in the wild-type strainand Chieh Chang. For the body bends/minute in Table 2,
N2 as measured by a dispersal assay (see materialsonly forward waves were recorded and the clock was paused
during a reversal; waves preceding or following a reversal and methods) is 0.75 6 0.02 vol% (0.4 mm aqueous
were not included. Entries for each animal were averaged concentration), which is similar to the 0.31 mm concen-
and converted to waves and reversals per minute. For each tration required to anesthetize humans (Franks andgenotype, the mean 6 standard deviation value of several
Lieb 1993). We measured the isoflurane sensitivity ofanimals (n 5 25–28) is reported. For the body bends/minute
four different goa-1 loss-of-function mutants and foundin Table 4, again only forward waves were recorded but the
clock was not paused for reversals; this methodological differ- them all to be significantly resistant compared to N2
ence was used because of the locomotion phenotypes of unc- (Figure 1; Table 1) The EC50 for goa-1(n363), which
64(rf ) mutants, which unlike goa-1(lf ) mutants tend to pause carries a null mutation deleting the entire goa-1 codingtheir movement before or after reversals for extended periods
region (Segalat et al. 1995), is 1.40 6 0.06 or 87%(n 5 10 animals/genotype). The significance of differences
higher than N2. Two other goa-1(lf ) alleles, goa-1(n1134)between values was determined by a two-tailed Student’s t-test.
Sequence analysis of sy192: Five overlapping fragments span- (Segalat et al. 1995) and goa-1(pk62) (Mendel et al.
ning the goa-1 coding region were amplified in both wild-type 1995), are similarly isoflurane resistant. A fourth Go
and sy192 genomic DNA in three independent reactions using a-subunit mutation, goa-1(sy192) (Mendel et al. 1995),
long range PCR (Boehringer Mannheim, Indianapolis).
was even more resistant to isoflurane, with an EC50 ofPrimer sequences are available on request. The products of
1.77 6 0.13 vol% isoflurane.the PCR reactions were pooled and subcloned into pGEM
(Promega, Madison, WI). Three independent plasmids for each goa-1 allelic variation for halothane sensitivity: Halo-
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TABLE 1
Anesthetic phenotypes of goa-1(lf) mutants
Halothane Isoflurane
Strain Native DIa EC50 (vol%)b Slopec EC50 (vol%)b Slopec
N2 (wild type) 0.90 6 0.01 0.42 6 0.03 1.82 6 0.24 0.75 6 0.02 3.50 6 0.33
goa-1(sy192) 0.98 6 0.01 1.07 6 0.04* 2.88 6 0.38 1.77 6 0.13* 2.44 6 0.49
goa-1(n363) 0.95 6 0.01 0.48 6 0.02 3.17 6 0.48 1.40 6 0.06* 2.76 6 0.35
goa-1(n1134) 0.96 6 0.02 0.47 6 0.05 3.40 6 0.90 1.29 6 0.06* 2.67 6 0.45
goa-1(pk62) 0.66 6 0.08 0.45 6 0.05 3.50 6 1.1 1.37 6 0.08* 3.90 6 0.64
* P , 0.01, significantly resistant to the anesthetic when compared to wild-type curve by simultaneous curve
fitting (DeLean et al. 1978).
a Dispersal index without VAs (mean 6 SEM; n . 3).
b Estimated VA concentration where effect is half-maximal 6 standard error of the estimate; replicate
experiments were pooled and refitted by the logistic equation as described in materials and methods.
c The slope of the curve used to estimate the corresponding EC50; for each VA none of the slopes are
significantly different.
thane is a structurally distinct volatile anesthetic that is and locomotion behaviors (Mendel et al. 1995; Segalat
z1.5-fold more potent than isoflurane in both C. elegans et al. 1995). Reduction-of-function mutations in goa-1
and humans (Franks and Lieb 1994; Crowder et al. cause eggs to be laid at an abnormally early stage of
1996), with an EC50 of 0.42 6 0.03 vol% in the N2 wild- development; goa-1(rf ) also confers a hyperactive move-
type strain. We measured the halothane sensitivity of ment phenotype. We measured egg laying and two as-
the four goa-1 alleles (Table 1). Surprisingly, only goa-1 pects of locomotion in the n363, n1134, and sy192 al-
(sy192) was resistant to halothane with an EC50 .2-fold leles. As reported previously (Mendel et al. 1995; Segalat
that of wild type (Figure 2). The other three alleles had et al. 1995), the three tested goa-1(rf ) alleles lay eggs at
halothane EC50s virtually identical to N2. an earlier stage than does the wild-type strain (Table
To evaluate the allelic variation of goa-1 mutants in 2). Forward speed is increased significantly in the null
their halothane sensitivity, we determined the genetic mutants but to a much greater degree in sy192 (Table
behavior and molecular identity of the sy192 allele and 2). The frequency of change from forward to backward
compared that to n363 and n1134. Previously, all goa-1 locomotion (reversal of direction) is also increased sig-
alleles have been shown to have abnormal egg-laying nificantly in all of the goa-1 alleles. Unlike n363 and
n1134, which are recessive, sy192 acts in a dominant
fashion against both egg laying and forward locomotion
(Table 2).
To help us understand the differences in phenotypes
and genetic behavior between sy192 and the other goa-1
alleles, goa-1(sy192) was sequenced. Sequencing of the
goa-1(sy192) gene and comparison to the previously pub-
lished wild-type sequence (Lochrie et al. 1991) identi-
fied a single missense mutation (ACT–ATT) that con-
verts the threonine at position 330 to isoleucine. This
is a relatively unconserved residue near the C-terminal
end of the protein not previously shown to be essential
for Go function. As mentioned above, n363 has an 11-kb
deletion of the entire coding region and upstream se-
quences of the goa-1 gene (Segalat et al. 1995); thus,
it is a null mutation by molecular criteria. n1134 carries
a missense mutation in the consensus sequence for
N-terminal myristoylation (Segalat et al. 1995). Myris-Figure 2.—Halothane concentration-response curves for
toylation has previously been shown to be required forthe N2, goa-1(sy192), and goa-1(n363) strains. goa-1(sy192) is
significantly resistant to halothane (P , 0.01) compared to function of G protein a-subunits (Mumby et al. 1990;
the wild-type strain N2 by simultaneous curve fitting, but goa-1 Linder et al. 1991; Denker et al. 1992a). Thus, n1134
(n363) is not. Data points for similar isoflurane concentrations would be expected to behave as a null mutation. Indeed,are pooled for N2, and the mean 6 SEM of the concentrations
n1134/n363 heterozygotes are phenotypically indistin-and dispersal indices are represented by horizontal and verti-
cal error bars, respectively. guishable from n1134 homozygotes consistent with
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TABLE 2
Behavioral phenotypes of goa-1 mutants
Movement
Egg layinga
Strain % early eggs Body bends/minuteb Reversals/minutec
N2 (wild type) 10 (60) 24.9 6 4.5 (26) 0.8 6 0.7 (26)
goa-1(n363) 100 (20) 27.3 6 3.8* (25) 4.7 6 0.9* (25)
goa-1(n1134) 100 (38) 29.9 6 4.4* (28) 3.5 6 1.3* (28)
goa-1(sy192) 96 (56) 40.1 6 3.7† (27) 5.0 6 1.0* (27)
n363/1 19 (74) 26.9 6 3.3 (26) 0.6 6 0.6 (26)
n1134/1 13 (119) 27.6 6 5.9 (26) 0.6 6 0.6 (26)
sy192/1 92 (72) 44.4 6 3.1† (27) 1.2 6 0.8 (27)
a Newly laid eggs with eight or fewer cells were defined as early. No. of eggs scored is given in parentheses.
b Average body bends/minute over a 2-min assay period 6 SD. *, significantly different from wild type (P ,
0.05). †, significantly different from N2, n363, and n1134 (P , 0.0001). No. of hermaphrodites scored is given
in parentheses.
c Average no. of times backward movement was initiated/minute over a 2-min assay period 6 SEM. *,
significantly different from wild type (P , 0.0001). No. of hermaphrodites scored is given in parentheses.
n1134 being a functional null allele of goa-1 (data not shocked controls (Figure 3B). Heat-shock of nontrans-
formed goa-1(sy192) did not alter its halothane resis-shown). Thus, the phenotypes of n363 not sy192 are
most likely to represent the null phenotypes of the goa-1 tance (data not shown).
VA resistance by other genes in the goa-1 pathway: Tolocus. The genetic (lack of haploinsufficiency of n363),
behavioral, and molecular data suggest that the sy192 define the upstream and downstream GOA-1 signaling
molecules that regulate VA action, we measured themutation acts in a dominant negative fashion and pro-
duces a phenotype even more severe than the null phe- VA sensitivity of mutants with altered GOA-1 signaling
(Table 3). egl-10 codes for an RGS (regulator of G pro-notype.
Transformation rescue of goa-1(lf) VA resistance: The tein signaling) protein acting upstream of goa-1 (Koelle
and Horvitz 1996). RGS proteins inhibit G proteinisoflurane resistance of four strains carrying indepen-
dently generated reduction-of-function mutations in activity by catalyzing the hydrolysis of the G protein
a-subunit to its inactive GDP-bound state (Dohlmangoa-1 is very strong evidence that the known mutations
in goa-1 are indeed responsible for that phenotype. How- and Thorner 1997). Overexpression of egl-10 results in
behavioral defects similar to those caused by goa-1(lf )ever, the halothane resistance phenotype was unique to
goa-1(sy192). Thus, we attempted transformation rescue (Koelle and Horvitz 1996). egl-10(nIs51) and egl-10
(nIs54), which both carry integrated multicopy egl-10of the halothane resistance phenotype of sy192. goa-1
(sy192);dpy-20(e1282) was transformed with an extra- transgenes, are resistant to both halothane and isoflur-
ane (Table 3). Therefore, for halothane sensitivity, over-chromosomal array carrying the wild-type goa-1 and
dpy-20 genes. Non-Dpy (sy192;e1282 mutants carrying expressers of egl-10 phenocopy the missense goa-1(sy192)
mutant not the null mutants. Two reduction-of-functionthe array) animals had halothane EC50s fourfold less
than their Dpy sibs (sy192;e1282 mutants that lost the egl-10 mutants were also tested, egl-10(md176) and the
behaviorally less severe egl-10(n480). Both alleles showarray) and about fivefold less than untransformed goa-1
(sy192) (Figure 3, A and B). The isoflurane resistance a statistically insignificant decrease in halothane and
isoflurane sensitivity.of sy192 was similarly rescued by goa-1(1) expression
(Figure 3B). The syEx352 array was crossed into goa-1 The sag (suppressors of activated G protein) genes
function opposite to and downstream of or parallel to(n363) without dpy-20(e1282), and goa-1(n363);syEx352
(array-containing animals were identified by their Egl goa-1 (Hajdu-Cronin et al. 1999). Reduction-of-func-
tion mutations in the sag genes suppress the nearlyphenotype) was tested for rescue of isoflurane resis-
tance. n363;syEx352 animals had fourfold lower isoflur- paralyzed goa-1(gf) phenotype of goa-1(syIs17), which car-
ries integrated copies of a heat-shock-inducible goa-1ane EC50s than their non-Egl siblings (Figure 3B). Fi-
nally, we asked whether the halothane resistance of gain-of-function construct (Mendel et al. 1995). We hy-
pothesized that one or both of these sag(rf ) mutantssy192 could be rescued if goa(1) expression was delayed
until the adult stage at the same time as the anesthetic might be resistant to VAs. We measured the VA sensitiv-
ity of these two sag strains in the goa-1(syIs17) back-assays. To answer this question, we drove expression of
goa-1(1) with a heat-shock-inducible promoter. Indeed, ground at the permissive room temperature, thereby
testing the sag mutations in the absence of activatedheat-shocked non-Dpy animals (carrying the array) were
twofold more sensitive to halothane than non-heat- goa-1. None of the sag-1(rf ) alleles tested (also known
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as dgk-1) are halothane or isoflurane resistant; however,
both alleles of eat-16 (after isolation sag-2(sy438) was
shown to be allelic to a previously identified eat-16 muta-
tion) are resistant to both halothane and isoflurane
(Table 3). Thus, a relatively specific aspect of GOA-1’s
function, which is suppressed by eat-16(rf ) but not by
sag-1(rf ), mediates its effect on VA action.
As discussed above, Goa has been shown in vertebrate
neurons to regulate presynaptic Ca21 channels in a syn-
taxin-dependent manner (Stanley and Mirotznik
1997). unc-64 codes for the only known C. elegans neu-
ronal syntaxin and profoundly regulates VA sensitivity
(van Swinderen et al. 1999). Two unc-64(rf) alleles are
VA hypersensitive and one, unc-64(md130), is VA resis-
tant; the halothane and isoflurane EC50s of these alleles
differ by 7- and 30-fold, respectively. We have hypothe-
sized that unc-64(md130) confers its resistance by some-
how blocking the binding or transduction of binding
of VAs whereas the hypersensitive syntaxin mutants are
altering VA sensitivity indirectly (van Swinderen et al.
1999). To examine the relationship between Goa and
syntaxin in regulating VA sensitivity, we generated dou-
ble mutant strains carrying both goa-1(n363) and each
of the three unc-64(rf) mutations. Double mutant strains
with goa-1(n363) and either of the two VA hypersensitive
unc-64 mutations had anesthetic phenotypes similar to
goa-1(n363) (Table 4); that is, they were resistant to
isoflurane and normally sensitive to halothane. How-
ever, the anesthetic phenotype of n363 in combination
with the VA-resistant unc-64(md130) mutation was quali-
tatively similar to md130 (i.e., halothane and isoflurane
resistant). However, quantitatively the isoflurane resis-
Figure 3.—Transformation rescue of goa-1(rf ) VA resistance tance of the double mutant was intermediate betweenphenotypes. (A) Concentration-response curves for goa-1(sy192);
that of either single mutant. In other words, the isoflur-e1282 with and without the rescuing array: syEx352[goa-1(1);dpy
ane resistance phenotypes are not additive; rather, the20(1)]. The curve for goa-1(sy192) is shown for comparison. (B)
Summary of VA sensitivities of array- and nonarray-containing high-level resistance of unc-64(md130) is in part sup-
rescued strains. The genotypes of the strains are as follows: pressed by goa-1(n363).
PS3479, goa-1(sy192); dpy-20(e1282); syEx352[goa-1(1); dpy-20(1)];
Anesthetic resistance is not secondary to behavioralMC21, goa-1(n363);syEx352; PS3480, goa-1(sy192); dpy-20(e1282);
hyperactivity: We questioned whether the VA resistancesyEx353[pHS::goa-1(1); dpy-20 (e1282)]. For PS3479 and PS3480,
the array was assumed to be present in non-Dpy animals and phenotypes were influenced by the native dispersal of
absent in Dpy animals. For MC21, Egl animals were scored as the animals in the absence of anesthetics. In the absence
having the array. Anesthetic sensitivity was measured by the dis- of anesthetic, some of the VA-resistant strains perform
persal assay with six- to eight-point dose-response curves using the
better than N2 in air (Tables 1, 2, and 3), raising thedispersal assay with one alteration: the dispersal indices were
possibility that their resistance was an artifact of theirscored with the observer blinded to the anesthetic concentration.
The number of dispersal assays per strain were: PS3479 (halo- hyperactivity. To examine this issue directly, we altered
thane), 4; PS3479 (isoflurane), 2; PS3480, 2; MC21, 2; sy192, 4. the assay in two ways and tested the most hyperactive
The anesthetic sensitivities of transformed and untransformed of the strains, goa-1(sy192). First, we shortened the timesiblings were measured on the same dispersal assay plates simulta-
allowed for dispersal from 45 min to 25 min, therebyneously. For heat-shock experiments, heat-shocked and non-heat-
increasing the difficulty of the task and increasing theshocked animals were grown and tested in parallel. EC50s (slopes)
for the curves were: PS3479 (halothane) array 1: 0.22 6 0.03 assay’s sensitivity to locomotion defects. This modifica-
(1.1 6 0.17), array 2: 0.87 6 0.06 (4.2 6 1.3); PS3479 (isoflurane) tion brings the native dispersal index of goa-1(sy192)
array 1: 0.74 6 0.06 (2.1 6 0.23), array 2: 1.54 6 0.12 (3.7 6 down to z70%, below that of N2 in the standard assay.1.1); MC21 (isoflurane) array 1: 0.43 6 0.03 (2.1 6 0.39), array
Second, we lengthened the animals’ preassay exposure2: 1.61 6 0.10 (3.8 6 1.0); PS3480 (halothane) HS: 0.36 6 0.07
to anesthetics from 5 min to 15 min by increasing the(2.3 6 0.86), no HS: 0.74 6 0.08 (3.7 6 1.8). *, significantly
different from nonarray or non-HS sibs, P , 0.01 by simultaneous initial spotting volume (see materials and methods)
curve fitting. to 20 ml. This second modification allowed the anesthe-
tic more time to take effect in case these mutants man-
aged to get a “head start” before being fully affected by
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TABLE 3
Anesthetic phenotypes of mutations in the goa-1 pathway
Halothane Isoflurane
Strain Native DIa EC50 (vol%)b EC50 (vol%)b Molecular lesionc
N2 0.90 6 0.01 0.42 6 0.03 0.75 6 0.02 Wild type
egl-10(nIs51) 0.99 6 0.01 1.06 6 0.04* 2.25 6 0.18* Transgene gf
egl-10(nIs54) 0.89 6 0.04 1.14 6 0.09* 1.43 6 0.07* Transgene gf
egl-10(md176) 0.50 6 0.04 0.45 6 0.12 0.43 6 0.07 Rearrangement-null
egl-10(n480) 0.80 6 0.04 0.52 6 0.01 0.81 6 0.04 Weak missense lf
sag-1(sy428)d 0.47 6 0.03 0.28 6 0.02 0.58 6 0.05 Strong lf
sag-1(sy429) 0.62 6 0.03 0.44 6 0.04 0.88 6 0.07 rf
sag-1(nu199) 0.85 6 0.05 0.36 6 0.04 0.78 6 0.11 rf
sag-1(md1777) 0.84 6 0.02 0.45 6 0.05 0.67 6 0.06 rf
eat-16(sy438) 0.90 6 0.03 0.73 6 0.04* 1.20 6 0.07* Missense rf
eat-16(ad702) 0.90 6 0.03 1.10 6 0.04* 1.33 6 0.06* Missense rf
* P , 0.01, significantly resistant to the anesthetic when compared to wild-type curve by simultaneous curve
fitting (DeLean et al. 1978).
a Dispersal index without VAs (mean 6 SEM; n . 3).
b Estimated VA concentration where effect is half-maximal 6 standard error of the estimate; replicate
experiments were pooled and refitted by the logistic equation as described in materials and methods.
c gf, gain-of-function; rf, reduction-of-function; lf, loss-of-function.
d sag-1 is also known as dgk-1.
the drug. However, this seemed unlikely since we have and the double mutant n363;md1259 disperse signifi-
cantly less than N2 in air yet each is halothane and/orshown previously that VAs rapidly produce their behav-
ioral effects reaching a steady state within 10 min isoflurane resistant. Finally, the goa-1 alleles n363 and
n1134 disperse as well as sy192, yet neither is halothane(Crowder et al. 1996). The halothane EC50 of sy192 is
not decreased significantly by either modification of the resistant. Further, although not hyperactive by the dis-
persal assay, sag-1/dgk-1(rf ) alleles have been noted toassay (EC50 @ 25 min 5 0.93 6 0.02; EC50 w/ 20-ml
drop 5 1.17 6 0.05). Moreover, not all VA-resistant be hyperactive in other locomotion assays (Hajdu-Cro-
nin et al. 1999; Miller et al. 1999; Nurrish et al. 1999),strains are hyperactive. eat-16(sy438), eat-16(ad702), and
egl-10(nIs54) performed similarly to N2 in the absence yet these strains are not anesthetic resistant (Table 3).
Therefore, hyperactivity is neither necessary nor suffi-of anesthetics, yet all are resistant to both halothane
and isoflurane. goa-1(pk62), goa-1(sy192);dpy-20(e1282), cient to produce VA resistance.
TABLE 4
Phenotypes of goa-1;unc-64 double mutants
MI on aldicarb
Halothane Isoflurane
Strains EC50 vol%a EC50 vol%a Native DI BBM 0.1 mm 0.5 mm
N2 0.42 6 0.03 0.75 6 0.02 0.90 6 0.01 18.6 6 0.84 0.79 6 0.02 0.03 6 0.03
goa-1(n363) 0.43 6 0.03 1.46 6 0.06b 0.95 6 0.01b 18.6 6 1.08 0.05 6 0.02b 0 6 0
unc-64( js21) 0.17 6 0.03b 0.13 6 0.04b 0.64 6 0.04b 4.8 6 0.82b 0.81 6 0.04 0.70 6 0.01b
unc-64(md1259) 0.17 6 0.10b 0.18 6 0.02b 0.38 6 0.05b 10.2 6 1.25b 0.72 6 0.02 0.23 6 0.04
unc-64(md130) 1.29 6 0.12b 4.36 6 0.36b 0.64 6 0.02b 12.1 6 1.08b 0.95 6 0.05 0.65 6 0.10b
n363;js21 0.44 6 0.06c 1.15 6 0.14b,c 0.79 6 0.06 15.4 6 1.11c 0.93 6 0.02b,d 0.26 6 0.05b,c
n363;md1259 0.39 6 0.04e 1.52 6 0.13b,e 0.70 6 0.05b,e 18.8 6 1.16e 0.48 6 0.05b,d 0.01 6 0.01
n363;md130 0.97 6 0.09b,d 2.20 6 0.23b,d,f 0.75 6 0.04b,f 17.6 6 1.99f 0.60 6 0.06d,f 0 6 0f
Native DI 6 SEM, dispersal index in the absence of anesthetic; BBM 6 SEM, body bends/minute; MI 6 SEM on aldicarb,
fraction moving after incubation on 0.1 or 0.5 mm aldicarb agar pads. P , 0.01 set as significance threshold for all comparisons.
a EC50s 6 standard error of the estimate by dispersal assay and compared by simultaneous curve fitting (DeLean et al. 1978).
All other values are means 6 SEM and compared by two-sided t-test assuming unequal variances.
b Different from N2.
c Different from js21.
d Different from n363.
e Different from md1259.
f Different from md130.
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Anesthetic resistance is not secondary to an increase linergic transmission is neither sufficient nor necessary
to produce VA resistance. Levamisole is a direct acetyl-in cholinergic neurotransmission: Since VAs have been
shown to decrease cholinergic neurotransmission in choline receptor agonist used to identify postsynaptic
effects of C. elegans mutants. Neither goa-1(n363) or goa-1C. elegans (van Swinderen et al. 1999), disruption of
goa-1 signaling might indirectly confer VA resistance (sy192) differed from wild type in their levamisole sensi-
tivity or in VA effects on levamisole sensitivity (datasimply by elevating neurotransmitter release. To exam-
ine this question, we made use of the drug aldicarb. not shown). This further supports a presynaptic site of
action for goa-1 in regulating VA sensitivity.Aldicarb is an acetylcholinesterase inhibitor that pro-
duces a hypercontracted paralysis in C. elegans due to To further examine this issue, we looked at VA effects
on aldicarb sensitivity in various genetic backgroundsaccumulation of acetylcholine at the neuromuscular
junction (Rand and Nonet 1997). Mutants with defects (Figure 4). As shown previously (van Swinderen et al.
1999), halothane and isoflurane significantly reduce thein presynaptic machinery, for example, syntaxin mu-
tants, have shown that decreases in transmitter release potency of aldicarb in paralyzing wild-type animals (Fig-
ure 4, A and E). This result suggests that VAs reduceconfer aldicarb resistance (Nguyen et al. 1995; Miller
et al. 1996; Saifee et al. 1998). As had been shown pre- cholinergic neurotransmission. None of three mutants
in the goa-1 pathway that were tested [goa(n363), goa-1viously (Miller et al. 1999; Nurrish et al. 1999), goa-1
(n363) (Table 4) and the other three goa-1 alleles have (sy192), and egl-10(nIs51)] blocked or reduced halo-
thane-induced aldicarb resistance (Figure 4). However,an increase in cholinergic neurotransmission as evi-
denced by their aldicarb hypersensitivity; 0.1 mm aldi- the concentration/response curves did differ among
the strains at higher halothane concentrations. In thecarb produced nearly 100% paralysis in goa-1(lf ) com-
pared to 20% for wild type. Likewise, egl-10(nIs51) wild-type and goa-1(n363) strains, the fraction of animals
moving on aldicarb significantly decreases above 1 vol%(Figure 4) and egl-10(nIs54) [movement index (MI) @
0.1 mm 5 0.01 6 0.02] were aldicarb hypersensitive; halothane (Figure 4, A and B). In other words, halo-
thane appears to lose its ability to confer aldicarb resis-however, egl-10(md176), a reduction-of-function allele
(Table 3), was not aldicarb resistant (MI @ 0.5 mm 5 tance at higher concentrations. However, the movement
index on aldicarb of the halothane-resistant strains, goa-10.026 6 0.01 compared to N2 @ 0.5 mm 5 0.03 6
0.03). This result is consistent with the finding that egl- (sy192) and egl-10(nIs51), does not decrease at higher
halothane concentrations (Figure 4, C and D). The10(md176) is not VA hypersensitive.
While aldicarb hypersensitivity and increased trans- movement indices of goa-1(n363) and N2 were signifi-
cantly different (P , 1028) from goa-1(sy192) and egl-10mitter release generally correlate with VA resistance,
there are exceptions. Downstream of goa-1, both eat- (nIs51) in the 0.5–1.5 vol% halothane concentration
range. Unlike halothane, isoflurane did not have a bi-16(ad702) and sag-1(sy428) strains are, as had been
shown previously (Miller et al. 1999; Nurrish et al. modal effect on aldicarb sensitivity; rather, isoflurane
induces aldicarb resistance that does not decrease until1999), aldicarb hypersensitive (MI @ 0.1 mm: eat-16
(ad702) 5 0.09 6 0.02; sag-1(sy428) 5 0 6 0); however, very high concentrations (Figure 4E). These results sug-
gest that halothane has a secondary effect on neuro-eat-16(ad702) is VA resistant while sag-1(sy428) is not.
We also measured the aldicarb sensitivity of the goa-1 transmission not shared by isoflurane that is blocked
in the halothane-resistant goa-1(sy192) and egl-10(gf)(n363);unc-64(lf ) double mutants (Table 4). We sus-
pected given their locomotion behaviors that these VA- strains.
resistant mutants might have cholinergic transmission
similar to that of wild type. Indeed, both goa-1(n363);
DISCUSSION
unc-64(md1259) and goa-1(n363);unc-64(js21) had aldi-
carb sensitivities similar to that of N2 and much less Several mutants in the goa-1 signaling pathway were
shown to be VA resistant. We tested two anesthetics,than that of goa-1(n363) (Table 4); thus, increased cho-
c
Figure 4.—VAs induce resistance to the acetylcholinesterase inhibitor aldicarb. Wild-type or mutant C. elegans were exposed to
concentrations of aldicarb that paralyzed an average of 80–95% of adult animals. Subsequently, the paralyzed animals were exposed to
various concentrations of halothane or isoflurane, and the fraction of moving animals (MI) was scored after 1 hr. Each point represents
3–13 measurements at similar anesthetic concentrations; the mean 6 SEM of the anesthetic concentration is indicated by horizontal
error bars; the mean 6 SEM of the MI at each anesthetic concentration is plotted. (A) Halothane effects on aldicarb sensitivity in N2.
*, significantly different from MI for 0 halothane baseline. #, significantly different from pooled peak MI (defined as those from 0.22
to 0.47 vol% halothane). (B) goa-1(n363) is wild type for halothane-induced aldicarb resistance. n363, sy192, and nIs51 are hypersensitive
to aldicarb in the absence of halothane; thus, a lower aldicarb concentration is used. *, significantly different from MI for 0 halothane
baseline. #, significantly different from pooled peak MI (defined as those from 0.12 to 0.50 vol% halothane). (C) The aldicarb sensitivity
of goa-1(sy192) responds differently than wild type to halothane. *, significantly different from MI for 0 halothane baseline. (D) egl-
10(nIs51) is similar to sy192 in its response to halothane on aldicarb. *, significantly different from MI for 0 halothane baseline. (E)
Isoflurane effect on aldicarb sensitivity in N2. *, significantly different from MI for 0 isoflurane baseline.
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halothane and isoflurane, and found that some goa-1 sy192 and egl-10(gf) could be due to dominant negative
effects on the bg-subunit of Go or of some other Gmutants were resistant only to isoflurane (n363, n1134,
pk62) whereas other mutations in goa-1 pathway genes protein that regulates locomotion, egg laying, and anes-
thetic action. egl-10 encodes an RGS protein thought toconferred resistance to both isoflurane and halothane
[goa-1(sy192), egl-10(gf), eat-16(rf )]. The different anes- negatively regulate wild-type GOA-1 by increasing the
GTPase activity of the GOA-1 subunit (Koelle and Hor-thetic sensitivities of the strains, the results from testing
of the goa-1(n363);unc-64(rf) double mutants, and the vitz 1996; Koelle 1997); thus, egl-10(gf) mutants should
increase levels of aGDP and recruit bg-subunits awayaldicarb experiments suggest and exclude potential
mechanisms whereby GOA-1 controls VA action in C. from their target substrates (Dohlman and Thorner
1997). Likewise, the location of the sy192 mutation sug-elegans.
Is GOA-1 a VA target? By genetic and molecular crite- gests that sy192 may alter the equilibrium of G protein
signaling by also reducing bg activity. Although the resi-ria, both goa-1(n363) and goa-1(n1134) eliminate goa-1
activity (Segalat et al. 1995). Thus, not surprisingly, due altered in sy192 is not highly conserved, it is the
first residue of the carboxy-terminal a-helix and liesthese two alleles behaved similarly in all of our anesthe-
tic and behavioral assays. These goa-1 nulls were found immediately adjacent to a highly conserved region in-
volved in nucleotide binding (Noel et al. 1993). Theseto be significantly resistant to isoflurane’s effect on loco-
motion but to be similar to wild type for halothane regions have been implicated in receptor-mediated
GDP release and G protein activation (Denker et al.sensitivity. The absence of GOA-1 protein then appears
not to be sufficient for conferring halothane resistance. 1992b; Rasenick et al. 1994). Substitution at position
330 could reduce nucleotide exchange, locking the mu-Thus, while the a-subunit of Go clearly regulates anesthe-
tic action, it cannot be halothane’s primary target. In tant a-subunits in a GDP-bound state and competing
with wild-type Goa-subunits for receptors and/or bg-the case of isoflurane, goa-1(null) is much less resistant
than the syntaxin mutant unc-64(md130); thus, if GOA-1 subunits. Alternatively, excess or mutant Goa-subunit
could act against another G protein-coupled receptoris an isoflurane target it cannot be the only one. Rather,
the effect of GOA-1 signaling on VA sensitivity is more or an RGS protein. A dominant negative action of the
sy192 product against the EAT-16 RGS protein wouldplausibly indirect.
One possible indirect mechanism of GOA-1 regula- increase the activity of the Gq pathway and would also
be consistent with our results.tion of VA action is through its negative effects on trans-
mitter release. However, the resistance produced by mu- Downstream mediators of GOA-1 anesthetic regula-
tory activity: Reduction-of-function mutations in egl-30,tations that reduce GOA-1 activity cannot be explained
simply by counteracting the action of VAs on transmitter which codes for a homolog of Gqa, are lethargic, aldicarb
resistant, and epistatic to goa-1(lf ). Thus, Gq and Go func-release. Neither hyperactivity nor aldicarb hypersensitiv-
ity is necessary or sufficient for VA resistance. Further, tion antagonistically in regulating locomotion and trans-
mitter release in C. elegans, Gq functioning downstreamnone of the goa-1 pathway mutants blocks the activity
of clinical concentrations of halothane against aldicarb- of or parallel to Go (Hajdu-Cronin et al. 1999; Lackner
et al. 1999; Miller et al. 1999). Components of the Gqinduced paralysis. Thus, goa-1 does not appear to regu-
late VA action either by altering the levels of neurotrans- signaling cascade include the products of eat-16 and
sag-1/dgk-1. sag-1/dgk-1 codes for a diacylglycerol kinasemitter independent of VAs or by blocking the effect of
VAs on transmitter levels. However, it is possible that ortholog that reduces the activity of diacylglycerol
(DAG), which is likely to mediate, at least in part, stimu-these mutants disrupt transmitter release in a way not
detected by the pharmacological assay. Aldicarb sensitiv- lation of transmitter release by EGL-30 Gqa (Nurrish
et al. 1999). eat-16 encodes an RGS protein that acts toity is an indicator of steady state levels of acetylcholine
and does not directly measure the magnitude or coordi- negatively regulate EGL-30 Gqa (Hajdu-Cronin et al.
1999). Our findings that eat-16(rf ) but not sag-1/dgk-nation of individual synaptic events that would mediate
the locomotion disrupted by VAs. Addressing these 1(rf) mutants are VA resistant suggests that Gq regulates
VA sensitivity but through second messengers eitherquestions will require physiological techniques only re-
cently developed in C. elegans (Raizen and Avery 1994; distinct from or in addition to DAG.
Of the many proteins whose function is regulatedGoodman et al. 1998; Richmond et al. 1999).
A clue to GOA-1’s anesthetic regulatory activity is by Go/Gq, we favor syntaxin and/or syntaxin-binding
proteins as most likely to be VA targets. As mentionedprovided by the phenotypes of goa-1(sy192) and the egl-
10 overexpressing strains. These mutants are both halo- in the Introduction, syntaxin mutant alleles have a .30-
fold difference in their isoflurane sensitivity that cannotthane and isoflurane resistant. Further, in the absence
of anesthetics, sy192 has a locomotion phenotype more be explained by differences in the effects of the muta-
tions on syntaxin’s normal function (van Swinderen etsevere than that of the null mutants. Thus, loss of the
a-subunit of Go does not appear to eliminate completely al. 1999). Thus, syntaxin and syntaxin-binding proteins
including calcium channels, SNAP-25, VAMP, UNC-13,the activity of the GOA-1 pathway. We speculate on
the basis of the function of EGL-10 and nature of the UNC-18, and synaptotagmin are all candidate VA tar-
gets. Because of the severity of their locomotion defects,mutation in sy192 that the additional phenotypes of
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Figure 5.—Model for volatile
anesthetic action at presynaptic
terminals in C. elegans. Depicted
is a schematic of a presynaptic
terminal with a single synaptic
vesicle releasing neurotransmit-
ter and the gene products found
to regulate sensitivity to clinical
concentrations of VAs in C. eleg-
ans as reported here and pre-
viously (van Swinderen et al.
1999). The relationship between
proteins is based on epistasis ex-
periments reported here and
elsewhere (as cited in the text).
VAs are shown as binding to the
SNARE complex (syntax-
in, SNAP-25, and VAMP) al-
though other binding targets
(N/P-type calcium channels or
UNC-18 in complex with syn-
taxin) are also reasonable.
Arrows indicate positive regula-
tion; lines capped by bars indi-
cate negative regulation.
we have not been able to test the anesthetic sensitivity with syntaxin or not, are also reasonable VA targets. Go
either directly or indirectly through inhibition of Gqof strains with severe mutations in the latter three genes.
We have tested mutant alleles of both L-(egl-19) and regulates VA sensitivity and the resistance produced by
unc-64(md130). One potential mechanism for Go/Gq’snon-L-type (unc-2) calcium channels without finding a
strongly resistant strain (data not shown). The existing regulation of VA sensitivity is by altering phosphoryla-
tion states of the presynaptic transmitter release machin-weak reduction-of-function mutants of SNAP-25 and
VAMP are hypersensitive to anesthetic (van Swinderen ery. Phosphorylation is known to affect the association
of syntaxin with other synaptic proteins including SNAP-et al. 1999). While these results do not rule out any of
the gene products as VA targets because the mutations 25, mUNC-18, and N-type calcium channels (Fujita et
al. 1996; Shimazaki et al. 1996; Yokoyama et al. 1997).either are not nulls or move too poorly to test, we have
no direct genetic data showing that any one of these Thus, phosphorylation could alter both the effect of
VAs on synaptic proteins and the ability of the unc-proteins is required for VA sensitivity. Given that UNC-
13 is a DAG binding protein (Lackner et al. 1999) 64(md130) product to interact with the VA target and
block VA binding or its effect. Future experiments willcapable of dissociating UNC-18 n-Sec1 from UNC-64
syntaxin (Sassa et al. 1999), the lack of an effect of the be aimed at demonstrating that one or more proteins
that function downstream of GOA-1, such as those thatsag-1/dgk-1 mutations on VA sensitivity suggests that unc-
13 and unc-18 may not regulate VA action, or they do form the SNARE complex, are indeed VA targets and
at understanding how the goa-1 pathway regulates VAso in a DAG-independent manner.
Our working hypothesis prior to our findings re- sensitivity.
ported here was that VAs bound to the SNARE complex We thank Yvonne Hajdu-Cronin and Shahla Gharib for technical
and disrupted its function in mediating vesicle fusion assistance in sequencing goa-1(sy192) and Yvonne Hajdu-Cronin, Wen
Chen, and Russell Roberson for communication of unpublished re-and transmitter release and that the unc-64(md130)
sults. This work was supported by National Institutes of Health RO1product somehow prevented the binding or effect of
GM-55832-01 and RO1 GM-59781-02 (C.M.C.), the Foundation forbinding of VA to the SNARE complex. Here, we found
Anesthesia Education and Research (C.M.C.). P.W.S. is an investigator
that the high-level isoflurane resistance of unc-64 of the Howard Hughes Medical Institute. Some of the C. elegans strains
(md130) is in part dependent on the presence of normal used in this work were provided by the Caenorhabditis Genetics Cen-
ter, which is funded by the National Institutes of Health NationalGOA-1 activity. Thus, the syntaxin-mediated and GOA-
Center for Research Resources.1-mediated mechanisms of regulating VA action are not
additive. How might GOA-1 regulate VA action if the
VA target is indeed the SNARE complex? A working
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